HKDC1 promotes liver cancer stemness under hypoxia through stabilizing β-catenin

Abstract

Overall, our findings underscore HKDC1 as a prometastatic HK specifically expressed in the malignant compartment of primary liver tumors, thereby providing a mechanistic basis for targeting this enzyme in advanced liver cancer.